BMEA
Price
$1.33
Change
+$0.01 (+0.76%)
Updated
Jul 13 closing price
Capitalization
96.52M
20 days until earnings call
Intraday BUY SELL Signals
CAMP
Price
$4.50
Change
+$0.17 (+3.93%)
Updated
Jul 13 closing price
Capitalization
233.67M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs CAMP

BMEA vs CAMP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMEA vs. CAMP commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and CAMP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (BMEA: $1.33 vs. CAMP: $4.50)
Brand notoriety: BMEA and CAMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 64% vs. CAMP: 22%
Market capitalization -- BMEA: $96.52M vs. CAMP: $233.67M
BMEA [@Biotechnology] is valued at $96.52M. CAMP’s [@Biotechnology] market capitalization is $233.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCAMP’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • CAMP’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMEA and CAMP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while CAMP’s TA Score has 5 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 5 bearish.
  • CAMP’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CAMP is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а -3.62% price change this week, while CAMP (@Biotechnology) price change was +5.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

BMEA is expected to report earnings on Aug 03, 2026.

CAMP is expected to report earnings on Aug 13, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAMP($234M) has a higher market cap than BMEA($96.5M). BMEA YTD gains are higher at: 7.258 vs. CAMP (-26.591). CAMP has higher annual earnings (EBITDA): -50.29M vs. BMEA (-63.38M). CAMP has more cash in the bank: 99.2M vs. BMEA (44.7M). BMEA has less debt than CAMP: BMEA (1.24M) vs CAMP (2.12M). CAMP has higher revenues than BMEA: CAMP (3.93M) vs BMEA (0).
BMEACAMPBMEA / CAMP
Capitalization96.5M234M41%
EBITDA-63.38M-50.29M126%
Gain YTD7.258-26.591-27%
P/E RatioN/AN/A-
Revenue03.93M-
Total Cash44.7M99.2M45%
Total Debt1.24M2.12M58%
TECHNICAL ANALYSIS
Technical Analysis
BMEACAMP
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 21 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
CAMP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARBFX13.69N/A
N/A
Arbitrage R
QQMNX22.30N/A
N/A
Federated Hermes MDT Market Neutral IS
SSDCX28.90N/A
N/A
DWS Small Cap Growth C
JCMVX31.08N/A
N/A
JPMorgan Mid Cap Value C
FFBFX32.14N/A
N/A
Emerald Bkg & Finac Evolution - Inv

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ACET. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+0.76%
ACET - BMEA
40%
Loosely correlated
-3.17%
CLRB - BMEA
39%
Loosely correlated
-6.74%
CAI - BMEA
38%
Loosely correlated
+0.41%
HUMA - BMEA
36%
Loosely correlated
-0.36%
MLTX - BMEA
36%
Loosely correlated
+0.25%
More

CAMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAMP has been loosely correlated with TARA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CAMP jumps, then TARA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAMP
1D Price
Change %
CAMP100%
+3.93%
TARA - CAMP
34%
Loosely correlated
-3.24%
HOWL - CAMP
31%
Poorly correlated
-15.26%
MGX - CAMP
28%
Poorly correlated
+3.94%
XENE - CAMP
27%
Poorly correlated
-1.74%
BMEA - CAMP
25%
Poorly correlated
+0.76%
More